ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 247 filers reported holding ICU MED INC in Q4 2022. The put-call ratio across all filers is 4.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,539,281 | -6.7% | 10,564 | +21.3% | 0.00% | 0.0% |
| Q2 2023 | $1,649,701 | -14.2% | 8,706 | -27.4% | 0.00% | 0.0% |
| Q4 2022 | $1,923,038 | +11.9% | 11,992 | +7.8% | 0.00% | 0.0% |
| Q3 2022 | $1,718,000 | -5.3% | 11,120 | +9.3% | 0.00% | 0.0% |
| Q2 2022 | $1,815,000 | +40.0% | 10,175 | +80.0% | 0.00% | 0.0% |
| Q1 2022 | $1,296,000 | -77.6% | 5,653 | -76.6% | 0.00% | -66.7% |
| Q4 2021 | $5,791,000 | -60.0% | 24,177 | -58.8% | 0.00% | -57.1% |
| Q3 2021 | $14,494,000 | +698.1% | 58,664 | +577.6% | 0.01% | +600.0% |
| Q2 2021 | $1,816,000 | +26.3% | 8,657 | +22.9% | 0.00% | 0.0% |
| Q1 2021 | $1,438,000 | -5.7% | 7,043 | +2.8% | 0.00% | 0.0% |
| Q4 2020 | $1,525,000 | +44.8% | 6,852 | +18.5% | 0.00% | 0.0% |
| Q3 2020 | $1,053,000 | +185.4% | 5,784 | +183.4% | 0.00% | – |
| Q2 2020 | $369,000 | -27.9% | 2,041 | -18.4% | 0.00% | -100.0% |
| Q1 2020 | $512,000 | -45.8% | 2,500 | -50.4% | 0.00% | 0.0% |
| Q4 2019 | $944,000 | -83.9% | 5,043 | -86.3% | 0.00% | -80.0% |
| Q3 2019 | $5,865,000 | -36.6% | 36,746 | +0.1% | 0.01% | -37.5% |
| Q2 2019 | $9,247,000 | -1.1% | 36,706 | -6.0% | 0.01% | 0.0% |
| Q1 2019 | $9,350,000 | -53.7% | 39,069 | -55.6% | 0.01% | -57.9% |
| Q4 2018 | $20,213,000 | +48.0% | 88,028 | +82.3% | 0.02% | +72.7% |
| Q3 2018 | $13,654,000 | +30.2% | 48,288 | +35.3% | 0.01% | +22.2% |
| Q2 2018 | $10,483,000 | -13.2% | 35,700 | -25.4% | 0.01% | -18.2% |
| Q1 2018 | $12,079,000 | +166.1% | 47,851 | +127.6% | 0.01% | +175.0% |
| Q4 2017 | $4,540,000 | +1476.4% | 21,020 | +1257.9% | 0.00% | – |
| Q3 2017 | $288,000 | +84.6% | 1,548 | +71.2% | 0.00% | – |
| Q2 2017 | $156,000 | +13.0% | 904 | 0.0% | 0.00% | – |
| Q1 2017 | $138,000 | -15.9% | 904 | -16.8% | 0.00% | – |
| Q4 2016 | $164,000 | +10.8% | 1,086 | -6.9% | 0.00% | – |
| Q3 2016 | $148,000 | +11.3% | 1,167 | -0.4% | 0.00% | – |
| Q2 2016 | $133,000 | -2.2% | 1,172 | -10.3% | 0.00% | – |
| Q1 2016 | $136,000 | -51.8% | 1,307 | -47.6% | 0.00% | – |
| Q4 2015 | $282,000 | +34.3% | 2,492 | +29.8% | 0.00% | – |
| Q3 2015 | $210,000 | +16.7% | 1,920 | +1.9% | 0.00% | – |
| Q2 2015 | $180,000 | +11.8% | 1,884 | +9.2% | 0.00% | – |
| Q1 2015 | $161,000 | +794.4% | 1,726 | +702.8% | 0.00% | – |
| Q4 2014 | $18,000 | +28.6% | 215 | 0.0% | 0.00% | – |
| Q3 2014 | $14,000 | -58.8% | 215 | -62.6% | 0.00% | – |
| Q2 2014 | $34,000 | +78.9% | 575 | +79.1% | 0.00% | – |
| Q1 2014 | $19,000 | -51.3% | 321 | -48.1% | 0.00% | – |
| Q4 2013 | $39,000 | -7.1% | 618 | 0.0% | 0.00% | – |
| Q3 2013 | $42,000 | -4.5% | 618 | 0.0% | 0.00% | – |
| Q2 2013 | $44,000 | – | 618 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |